BIT Capital GmbH Purchases 23,588 Shares of Axon Enterprise, Inc $AXON

BIT Capital GmbH increased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 667.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,123 shares of the biotechnology company’s stock after buying an additional 23,588 shares during the quarter. BIT Capital GmbH’s holdings in Axon Enterprise were worth $15,404,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in Axon Enterprise by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 9,367,224 shares of the biotechnology company’s stock worth $5,319,928,000 after buying an additional 53,060 shares in the last quarter. Geode Capital Management LLC grew its position in Axon Enterprise by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 2,226,159 shares of the biotechnology company’s stock worth $1,265,657,000 after buying an additional 35,544 shares in the last quarter. Baillie Gifford & Co. grew its position in Axon Enterprise by 1,198.7% during the fourth quarter. Baillie Gifford & Co. now owns 1,642,578 shares of the biotechnology company’s stock worth $932,869,000 after buying an additional 1,516,099 shares in the last quarter. Norges Bank acquired a new stake in Axon Enterprise during the fourth quarter worth approximately $515,764,000. Finally, Massachusetts Financial Services Co. MA boosted its holdings in shares of Axon Enterprise by 23.0% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 838,289 shares of the biotechnology company’s stock valued at $476,089,000 after purchasing an additional 156,647 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on AXON shares. JPMorgan Chase & Co. raised their target price on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Craig Hallum reaffirmed a “buy” rating and issued a $820.00 target price on shares of Axon Enterprise in a report on Wednesday, February 25th. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. UBS Group reduced their target price on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th. Finally, Wall Street Zen raised Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $712.75.

Axon Enterprise Stock Performance

AXON stock opened at $486.12 on Friday. The stock has a 50-day moving average price of $408.04 and a 200-day moving average price of $491.92. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $885.91. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The firm has a market cap of $39.18 billion, a PE ratio of 195.23, a price-to-earnings-growth ratio of 9.33 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The business’s quarterly revenue was up 33.7% on a year-over-year basis. During the same period last year, the company posted $1.47 EPS. As a group, equities research analysts expect that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other news, Director Jeri Williams sold 629 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $469.64, for a total value of $295,403.56. Following the completion of the sale, the director directly owned 1,141 shares in the company, valued at $535,859.24. This trade represents a 35.54% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $400.00, for a total value of $800,000.00. Following the completion of the sale, the insider owned 52,813 shares of the company’s stock, valued at approximately $21,125,200. This represents a 3.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 3,548 shares of company stock valued at $1,542,775. 4.20% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.